A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GALNT6 | Polypeptide N-acetylgalactosaminyltransferase 6 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HOXD12 | Homeobox D12 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |